|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003017,
umls-concept:C0003364,
umls-concept:C0004147,
umls-concept:C0005823,
umls-concept:C0008976,
umls-concept:C0087111,
umls-concept:C0149721,
umls-concept:C0288171,
umls-concept:C0439849,
umls-concept:C0678951,
umls-concept:C0871261,
umls-concept:C1261322,
umls-concept:C1274040,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1710263,
umls-concept:C2911692
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-12-31
|
|
pubmed:abstractText |
The renin-angiotensin-aldosterone system (RAAS) is important for the development of hypertension, and several antihypertensive drugs target this system. Our aim was to determine whether specific single nucleotide polymorphisms (SNPs) in RAAS genes were related to the blood pressure (BP) lowering effect of antihypertensive treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0895-7061
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
8-13
|
|
pubmed:dateRevised |
2009-2-24
|
|
pubmed:meshHeading |
pubmed-meshheading:14700505-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:14700505-Angiotensinogen,
pubmed-meshheading:14700505-Antihypertensive Agents,
pubmed-meshheading:14700505-Atenolol,
pubmed-meshheading:14700505-Biphenyl Compounds,
pubmed-meshheading:14700505-Blood Pressure,
pubmed-meshheading:14700505-Double-Blind Method,
pubmed-meshheading:14700505-Female,
pubmed-meshheading:14700505-Genotype,
pubmed-meshheading:14700505-Humans,
pubmed-meshheading:14700505-Hypertension,
pubmed-meshheading:14700505-Hypertrophy, Left Ventricular,
pubmed-meshheading:14700505-Male,
pubmed-meshheading:14700505-Middle Aged,
pubmed-meshheading:14700505-Polymorphism, Single Nucleotide,
pubmed-meshheading:14700505-Renin-Angiotensin System,
pubmed-meshheading:14700505-Tetrazoles,
pubmed-meshheading:14700505-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
|
|
pubmed:affiliation |
Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden. lisa.kurland@medsci.uu.se
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
